
NFkB/IkB Inhibitors: Small Molecules and Peptides
NFkB1 (NFkB p50) and NFkB2 (NFkB p52) are class I members of the Rel/NFkB family of transcription factors that also includes RelA, c-Rel and RelB. Rel/NFkB members regulate expression of genes that participate in immune, apoptotic and oncogenic processes. Class I members lack a C-terminal transcriptional activation segment found in class II members, but contain an RHD (Rel homology domain) that mediates DNA binding, nuclear localization and dimerization. NFkB1 and NFkB2 105 and 100 kDa precursors are proteolytically cleaved to 50 and 52 kDa active subunits, respectively. NFkB is predominantly localized in the cytoplasm as a complex with inhibitory IkB proteins and is released and translocated to the nucleus after phosphorylation of IkB.
34 results for "NFkB/IkB Inhibitors Small Molecules and Peptides" in Products
Product Action
Conjugates
Low Endotoxin
Sample Size
Citations
Reviews
NFkB/IkB Inhibitors: Small Molecules and Peptides
NFkB1 (NFkB p50) and NFkB2 (NFkB p52) are class I members of the Rel/NFkB family of transcription factors that also includes RelA, c-Rel and RelB. Rel/NFkB members regulate expression of genes that participate in immune, apoptotic and oncogenic processes. Class I members lack a C-terminal transcriptional activation segment found in class II members, but contain an RHD (Rel homology domain) that mediates DNA binding, nuclear localization and dimerization. NFkB1 and NFkB2 105 and 100 kDa precursors are proteolytically cleaved to 50 and 52 kDa active subunits, respectively. NFkB is predominantly localized in the cytoplasm as a complex with inhibitory IkB proteins and is released and translocated to the nucleus after phosphorylation of IkB.
34 results for "NFkB/IkB Inhibitors Small Molecules and Peptides" in Products
Proteasome and calpain inhibitor. Inhibits NF-κB activation
Alternate Names : | Z-LLL-al, Z-Leu-Leu-Leu-CHO |
Chemical Name : | N-[(Phenylmethoxy)carbonyl]-L-leucyl-N-[(1S)-1-formyl-3-methylbutyl]-L-leucinamide |
Purity : | ≥95% (HPLC) |
Irreversible inhibitor of TNF-α-induced IκBα phosphorylation
Alternate Names : | Bay 11-7083 |
Chemical Name : | (2E)-3-[[4-(1,1-Dimethylethyl)phenyl]sulfonyl]-2-propenenitrile |
Purity : | ≥99% (HPLC) |
RAGE antagonist
Purity : | ≥95% (HPLC) |
Inhibits TNF-induced NF-κB activation
Chemical Name : | 4-[(1E)-2-(3,5-Dihydroxyphenyl)ethenyl]-1,2-benzenediol |
Purity : | ≥98% (HPLC) |
NF-κB and AP-1 dual inhibitor
Chemical Name : | N-[3,5-Bis(trifluoromethyl)phenyl]-2-chloro-4-(trifluoromethyl)-5-pyrimidinecarboxamide |
Purity : | ≥99% (HPLC) |
Selective inhibitor of TBK
Chemical Name : | 2-Amino-7-(1-methylethyl)-5-oxo-5H-[1]benzopyrano[2,3-b]pyridine-3-carboxylic acid |
Purity : | ≥99% (HPLC) |
Inhibitor of NF-κB activation; anti-inflammatory
Chemical Name : | (2E)-1-(2,4-Dihydroxy-6-methoxyphenyl)-3-phenyl-2-propen-1-one |
Purity : | ≥98% (HPLC) |
Potent MEK1 inhibitor. Also inhibits IκBα phosphorylation
Alternate Names : | (-)-Arctigenin |
Chemical Name : | (3R,4R)-4-[(3,4-Dimethoxyphenyl)methyl]dihydro-3-[(4-hydroxy-3-methoxyphenyl)methyl]-2(3H)-furanone |
Purity : | ≥98% (HPLC) |
Anti-inflammatory, antioxidant and free radical scavenger
Alternate Names : | 3',4',5,7-Tetrahydroxyflavone |
Chemical Name : | 2-(3,4-Dihydroxyphenyl)-5,7-dihydroxy-4H-1-benzopyran-4-one |
Purity : | ≥98% (HPLC) |
Specific inhibitor of NF-κB activation
Alternate Names : | CAPE |
Chemical Name : | 3-(3,4-Dihydroxyphenyl)-2-propenoic acid 2-phenylethyl ester |
Purity : | ≥98% (HPLC) |
Potent Nurr1 activator
Chemical Name : | 6-[4-[(2-Methoxyethoxy)methyl]phenyl]-5-methyl-3-phenyl-isoxazolo[4,5-c]pyridin-4(5H)-one |
Purity : | ≥98% (HPLC) |
PTEN inhibitor; induces necroptosis; anti-inflammatory
Chemical Name : | 5,8-Dihydroxy-2-[(1R)-1-hydroxy-4-methyl-3-penten-1-yl]-1,4-naphthalenedione |
Purity : | ≥98% (HPLC) |
Inhibits RNAPII-mediated transcription; antitumor, anti-inflammatory and immunosuppressive
Chemical Name : | (3bS,4aS,5aS,6R,6aR,7aS,7bS,8aS,8bS)-3b,4,4a,6,6a,7a,7b,8b,9,10-Decahydro-6-hydroxy-8b-methyl-6a-(1-methylethyl)trisoxireno[4b,5:6,7:8a,9]phenanthro[1,2-c]furan-1(3H)-one |
Purity : | ≥98% (HPLC) |
E2 ubiquitin (Ub) conjugating enzymes inhibitor
Alternate Names : | Bay 11-7082 |
Chemical Name : | (2E)-3-[(4-Methylphenyl)sulfonyl]-2-propenenitrile |
Purity : | ≥99% (HPLC) |
Novel IKK2-selective inhibitor
Chemical Name : | N-(6-Chloro-7-methoxy-9H-pyrido[3,4-b]indol-8-yl)-2-methyl-3-pyridinecarboxamide dihydrochloride |
Purity : | ≥98% (HPLC) |
Selective allosteric inhibitor of IKK; anti-inflammatory
Chemical Name : | N1-(1,8-Dimethylimidazo[1,2-a]quinoxalin-4-yl)-1,2-ethanediamine hydrochloride |
Purity : | ≥99% (HPLC) |
Selective inhibitor of IKK
Chemical Name : | N-(4-Pyrrolidin-1-yl-piperidin-1-yl)-[4-(4-benzo[b]thiophen-2-yl-pyrimidin-2-ylamino)phenyl]carboxamide hydrochloride |
Purity : | ≥98% (HPLC) |
Inhibits NOD1-induced NF-κB activation
Chemical Name : | 1-[(4-Methylphenyl)sulfonyl]-1H-benzimidazol-2-amine |
Purity : | ≥99% (HPLC) |
Inhibitor of IKKβ; also exhibits antibacterial activity
Chemical Name : | N-[3,5-Bis(trifluoromethyl)phenyl]-5-chloro-2-hydroxybenzamide |
Purity : | ≥99% (HPLC) |
Inhibits TNF-α-induced NF-κB activation
Chemical Name : | (9β,13α,14β,20α)-3-Hydroxy-9,13-dimethyl-2-oxo-24,25,26-trinoroleana-1(10),3,5,7-tetraen-29-oic acid |
Purity : | ≥99% (HPLC) |
Nurr1 activator; inhibits NF-κB-dependent gene expression
Chemical Name : | 3,3'-[(4-Chlorophenyl)methylene]bis[1H-indole] |
Purity : | ≥98% (HPLC) |
IKKβ inhibitor; attenuates NF-κB-induced gene expression
Chemical Name : | 4-Amino-[2',3'-bithiophene]-5-carboxamide |
Purity : | ≥98% (HPLC) |
Potent and selective IKKε inhibitor
Chemical Name : | 5-(5,6-Dimethoxy-1H-benzimidazol-1-yl)-3-[[2-(methylsulfonyl)phenyl]methoxy]-2-thiophenecarbonitrile |
Purity : | ≥98% (HPLC) |
Nrf2 pathway activator; also NF-κB pathway inhibitor; inhibits IKKβ
Chemical Name : | 2-Cyano-3,12-dioxooleana-1,9(11)-dien-28-oic acid methyl ester |
Blocks NF-κB activation; also anti-inflammatory and antioxidant
Chemical Name : | 5,3'-Diallyl-2,4'-dihydroxybiphenyl |
Purity : | ≥98% (HPLC) |